Biolynx SRL
4.8 FTEBiolynx reported total assets of €1.49m at the end of the 2025 financial year (annual accounts filed with the NBB on 11 May 2026), with 4.8 full-time equivalents.
The score of Biolynx shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +81 % Total assets +82 % Headcount (avg FTE) +71 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biolynx's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 100,835 € | ||||
| Equity | 586,138 € | ||||
| Cash | 194,032 € | ||||
| EBITDA | 163,913 € | ||||
| Total assets | €1.49m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 May 2026
- Year ended 31 Dec 2024filed on 11 Jun 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 14 Jun 2022
Biolynx's financial analysis
- Solvency39.3%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biolynx
Biolynx's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0628.875.744
- VAT number
- BE0628875744
- Peppol
- Registered · 0208:0628875744 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Apr 2015
- Registered office
- 9000 Ghent
- Size
- Micro · 4.8 FTE
- Latest accounts
- 2025 · filed on 11 May 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Biolynx (SRL) has been based in Ghent since 2015, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 100,835 € and equity of 586,138 €; its revenue is not published. With 4.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 39.3%, below the median of its sector (60.4%).
Companies similar to Biolynx
Companies in the same business, of comparable size and area, outside its group.
- Palmir Research and experimental development on natural sciences and engineering Wommelgem · balance sheet 4 €
- reMYND Technical testing and analysis Leuven · balance sheet €3.15m
- Eurofins Euraceta Technical testing and analysis Villers-le-Bouillet · balance sheet €2.06m
- Forwise Technical testing and analysis Fleurus · balance sheet €2.13m
- Progenus Technical testing and analysis Gembloux · balance sheet €1.41m
- V.D.C. Engineering Technical testing and analysis Wavre · balance sheet 935,071 €
- GRIP Technical testing and analysis Rotselaar · balance sheet 866,624 €
- Lareco Technical testing and analysis Marche-en-Famenne · balance sheet €2.62m
Frequently asked questions about Biolynx
What is the revenue of Biolynx?
Biolynx files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biolynx?
In Belgium, the VAT number is the company number prefixed with BE: BE0628875744 for Biolynx, if the company is VAT-registered. Its company number (CBE) is 0628.875.744.
Where is the registered office of Biolynx?
According to the CBE register, the registered office of Biolynx is in 9000 Ghent.
What is the equity of Biolynx?
At the close of the 2025 financial year, the equity of Biolynx amounts to 586,138 €, a solvency of 39.3% of total assets.
How many people work at Biolynx?
4.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Biolynx?
The register lists 1 active mandates at Biolynx. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biolynx
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →